BRIDION
These highlights do not include all the information needed to use BRIDION safely and effectively. See full prescribing information for BRIDION. BRIDION (sugammadex) Injection, for intravenous use Initial U.S. Approval: 2015
Approved
Approval ID
9e3eb206-5c35-2c93-e053-2a95a90a9df0
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 10, 2023
Manufacturers
FDA
Medical Purchasing Solutions, LLC
DUNS: 601458529
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
sugammadex
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code71872-7187
Application NumberNDA022225
Product Classification
M
Marketing Category
C73594
G
Generic Name
sugammadex
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMay 10, 2023
FDA Product Classification
INGREDIENTS (4)
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SUGAMMADEX SODIUMActive
Quantity: 100 mg in 1 mL
Code: ERJ6X2MXV7
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT